RYLP.F Stock Overview
Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 3/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
No risks detected for RYLP.F from our risk checks.
Koninklijke Philips N.V. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | €20.52 |
| 52 Week High | €24.18 |
| 52 Week Low | €17.78 |
| Beta | 0.78 |
| 1 Month Change | 3.38% |
| 3 Month Change | -9.80% |
| 1 Year Change | -3.23% |
| 3 Year Change | -64.18% |
| 5 Year Change | -51.94% |
| Change since IPO | -3.37% |
Recent News & Updates
Recent updates
Shareholder Returns
| RYLP.F | US Medical Equipment | US Market | |
|---|---|---|---|
| 7D | 1.7% | 1.6% | 1.0% |
| 1Y | -3.2% | -1.4% | 21.9% |
Return vs Industry: RYLP.F underperformed the US Medical Equipment industry which returned -0.5% over the past year.
Return vs Market: RYLP.F underperformed the US Market which returned 24.9% over the past year.
Price Volatility
| RYLP.F volatility | |
|---|---|
| RYLP.F Average Weekly Movement | 4.5% |
| Medical Equipment Industry Average Movement | 7.3% |
| Market Average Movement | 6.0% |
| 10% most volatile stocks in US Market | 16.8% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: RYLP.F has not had significant price volatility in the past 3 months.
Volatility Over Time: RYLP.F's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1891 | 69,656 | Roy Jakobs | www.philips.com |
Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally. The company operates through Diagnosis & Treatment Businesses, Connected Care Businesses, and Personal Health Businesses segments. It also provides diagnostic imaging solutions, includes magnetic resonance imaging, X-ray systems, and computed tomography (CT) systems and software comprising detector-based spectral CT solutions, as well as molecular and hybrid imaging solutions for nuclear medicine; echography solutions focused on diagnosis, treatment planning and guidance for cardiology, general imaging, obstetrics/gynecology, and point-of-care applications; integrated interventional systems, and interventional diagnostic and therapeutic devices to treat coronary artery and peripheral vascular disease.
Koninklijke Philips N.V. Fundamentals Summary
| RYLP.F fundamental statistics | |
|---|---|
| Market cap | US$18.72b |
| Earnings (TTM) | -US$488.85m |
| Revenue (TTM) | US$19.48b |
1.0x
P/S Ratio-39.0x
P/E RatioIs RYLP.F overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| RYLP.F income statement (TTM) | |
|---|---|
| Revenue | €18.17b |
| Cost of Revenue | €10.72b |
| Gross Profit | €7.45b |
| Other Expenses | €7.90b |
| Earnings | -€456.00m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
Apr 29, 2024
| Earnings per share (EPS) | -0.50 |
| Gross Margin | 40.99% |
| Net Profit Margin | -2.51% |
| Debt/Equity Ratio | 54.8% |
How did RYLP.F perform over the long term?
See historical performance and comparison